AKAN Akanda Corp.
USHealthcareAs of 2026-07-10 16:00
Why AKAN matters now
Akanda Corp. (AKAN) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.94 with -1.09% on the session and $321.7K in market capitalization; recent performance reads 1-month +34.02% and YTD +98.69%.
The latest financial table shown here is Q4 2025, with revenue of $258.1K, net income of $-44.8M, and EPS of $-655.12. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -1351.8%.
The latest indexable market news headline is "Coloured Ties Capital Announces Proposed Share Consolidation" from Newsfile Corp.
Additional event context on this page matters because recent insider activity includes HRT FINANCIAL LP filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.12
P/S
2.28
EV/EBITDA
-2.95
DCF Value
$-256.50
FCF Yield
-1351.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-382.7%
Operating Margin
-2022.7%
Net Margin
-17658.5%
ROE
1217.9%
ROA
-735.6%
ROIC
-232.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $258.1K | $-44.8M | $-655.12 |
| FY 2025 | $258.1K | $-45.7M | $-662.22 |
| Q2 2025 | $0.00 | $-815.0K | $-41.24 |
| Q4 2024 | $359.7K | $-1.4M | $-49.20 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
GB
Exchange
—
Beta
1.73
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.